- JP Morgan cut its Afya price target to $17.50 a share from $19.00.
JP Morgan lowered its price target on Afya to $17.50 a share from $19.00, trimming the implied upside it assigns to the Brazilian medical-education group. The revision is a target change rather than a fresh call on the business, so the prior rating and thesis carry forward unless the firm says otherwise.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.